Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
13.33
+0.01 (0.08%)
Nov 7, 2025, 4:00 PM EST - Market closed
Select Medical Holdings Revenue
Select Medical Holdings had revenue of $1.36B in the quarter ending September 30, 2025, with 7.22% growth. This brings the company's revenue in the last twelve months to $5.37B, up 45.29% year-over-year. In the year 2024, Select Medical Holdings had annual revenue of $5.19B with 7.48% growth.
Revenue (ttm)
$5.37B
Revenue Growth
+45.29%
P/S Ratio
0.31
Revenue / Employee
$121,741
Employees
44,100
Market Cap
1.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.19B | 361.13M | 7.48% |
| Dec 31, 2023 | 4.83B | 216.80M | 4.70% |
| Dec 31, 2022 | 4.61B | -1.60B | -25.71% |
| Dec 31, 2021 | 6.20B | 672.80M | 12.16% |
| Dec 31, 2020 | 5.53B | 77.79M | 1.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SEM News
- 9 days ago - Select Medical Holdings Corporation (SEM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Select Medical Holdings Corporation Announces Results For Its Third Quarter Ended September 30, 2025 and Cash Dividend - PRNewsWire
- 5 weeks ago - Select Medical Holdings Corporation to Announce Third Quarter 2025 Results on Thursday, October 30, 2025 - PRNewsWire
- 2 months ago - SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS - PRNewsWire
- 3 months ago - Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend - PRNewsWire
- 4 months ago - Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering - Seeking Alpha
- 4 months ago - Select Medical Holdings Corporation to Announce Second Quarter 2025 Results on Thursday, July 31, 2025 - PRNewsWire